NEW YORK, Feb. 13, 2012 \/PRNewswire\/ -- Reportlinker.com announces that a new market research report is available in its catalogue: <\/p>\n
Nanotechnology for Drug Delivery : Global Market for Nanocarriers <\/p>\n
http:\/\/www.reportlinker.com\/p0770731\/Nanotechnology-for-Drug-Delivery---Global-Market-for-Nanocarriers.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology<\/a> <\/p>\n Nanocarriers will account for 40% of a $136 billion nanotechnology-enabled drug delivery market by 2021. We forecast the total market size in 2021 to be US$136 billion, with a 60\/40 split between nanocrystals and nanocarriers respectively, although developing new targeted delivery mechanisms may allow more value to be created for companies and entrepreneurs. <\/p>\n Of the 10 nanocarrier technologies studied, liposomes and gold nanocarriers account for 45% of the total addressable market. Liposomes will offer the largest addressable market ($15 billion) in 2021 while gold nanocarriers will see the highest compound annual growth rate (CAGR)\u201453.8%\u2014in the next decade. <\/p>\n Drugs are loaded into nanocarriers (also called nanoshells or nanoparticles, between 1 and 100 nm), then transported through the body to the target site. This kind of targeted drug delivery for the treatment of cancers is one of the most anticipated and discussed benefits of nanotechnology-enabled medicine as it offers a level of accuracy in delivering drugs that far surpasses present methods. Typically over 90% of a drug is wasted in the body, which leads to unwanted side effects. Modern chemotherapy bombards patients with drugs in the hope that tumorous cells will be destroyed. The lack of specificity of current drug delivery techniques mean patients' healthy cells are destroyed indiscriminately along with cancer cells. <\/p>\n Using nanotechnology to combat cancer is not new. Abraxane, the first nanoparticulate drug delivery product for the treatment of breast cancer, launched six years ago. There are now hundreds of new nanotech-based treatments under development, ranging from reformulation of existing drugs to enhance their efficacy to radical new \"magic bullet\" therapies. <\/p>\n The healthcare market is changing. We are seeing a paradigm shift away from blockbusters and a 'one-size fits all' approach to a more personalised medicine based on an individual's unique genome and immune response. The more scientists learn about the molecular causes for disease the more targeted and effective nanotechnology-enabled drug delivery therapies will become. <\/p>\n Table of ContentsTABLE OF EXHIBITS 7 <\/p>\n EXECUTIVE SUMMARY 12 <\/p>\n CHAPTER 1 - INTRODUCTION 17REPORT SCOPE 17 <\/p>\n METHODOLOGY 18 <\/p>\n Procurement 18 <\/p>\n Calculation of CAGR 19 <\/p>\n THE NANOSCALE 20 <\/p>\n Two biological examples that illustrate nanoscale: 20 <\/p>\n CHAPTER 2 \u2013 NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE 22OVERVIEW OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE 22 <\/p>\n Why is Nanotechnology A Critical Application for Medicine and Biomedicine? 22 <\/p>\n Why Nanotechnology Is Needed for Medicine and Biomedicine 24 <\/p>\n WHAT ARE THE KEY DRIVERS FOR ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND <\/p>\n BIOMEDICINE? 27 <\/p>\n The Aim Of Drug Targeting 27 <\/p>\n Rapid Market Growth 28 <\/p>\n Market Drivers For Enhanced Drug Delivery 28 <\/p>\n Increasing Proportion of The Ageing Population 29 <\/p>\n Demand For More Affordable Health Care 31 <\/p>\n Public Health \u2013 Ending disease 31 <\/p>\n Demand for More Innovation 31 <\/p>\n Social responsibility 31 <\/p>\n THE KEY APPLICATIONS OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE 32 <\/p>\n How Nanotechnology Can Benefit Drug Delivery 33 <\/p>\n Nanotechnology in Medical and Biomedical Diagnostics 34 <\/p>\n Nanotechnology in Regenerative Medicine and Tissue Engineering 34 <\/p>\n Other Applications For Nanomaterials In The Medical And Pharmaceutical Sector 34 <\/p>\n PROMISING EXAMPLES OF NANOTECHNOLOGY ENABLED DRUG DELIVERY 35 <\/p>\n Case Study 1 \u2013 Magnetic Field Acts as \"Remote Control\" to Deliver Nanomedicine 35 <\/p>\n Case Study 2 - Adaptive Micro and Nanoparticles: Temporal Control Over Carrier <\/p>\n Properties to Facilitate Drug Delivery 36 <\/p>\n Case Study 3 \u2013 Fabrication of a Nanocarrier System Through Self-Assembly of Plasma <\/p>\n Protein And Its Tumour Targeting 39 <\/p>\n Case Study 4 \u2013 IBM And The Institute of Bioengineering And Nanotechnology Find <\/p>\n Breakthrough For MRSA 39 <\/p>\n CHAPTER 3 \u2013 RISK & REGULATION 43THREE KEY BARRIERS TO THE ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND <\/p>\n BIOMEDICINE 43 <\/p>\n Nanotoxicity Nanopollution and Nanosafety 43 <\/p>\n Ethical Considerations Of Nanotherapies 45 <\/p>\n Delayed Nanoregulation 46 <\/p>\n FIVE CURRENT & FUTURE CHALLENGES IN THE ADOPTION OF NANOTECHNOLOGY IN <\/p>\n MEDICINE AND BIOMEDICINE 48 <\/p>\n Current & Future Challenges of Nanosafety And Risk Management 48 <\/p>\n Current & Future Challenges of Nanoregulation 51 <\/p>\n Current & Future Challenges for the Nanomedicine Industry 53 <\/p>\n Current & Future Challenges of Sustained Innovation 54 <\/p>\n Current & Future Challenges of Cooperation 54 <\/p>\n CHAPTER 4 \u2013 MARKET FOR NANOCARRIERS 57GLOBAL MARKET ANALYSIS: 2000-2010 (WITHOUT SEGMENTATION) 57 <\/p>\n GLOBAL MARKET FORECAST: 2011-2021 (WITHOUT SEGMENTATION) 60 <\/p>\n DISCUSSION OF NANOPARTICLES & NANOCARRIERS 63 <\/p>\n Overview of The Key Nanotechnologies Used in Drug Delivery Sorted by Applications 63 <\/p>\n Nanopharmaceuticals 63 <\/p>\n Nanotechnology In Drug Delivery 63 <\/p>\n Nanobiotechnology In Drug Delivery 64 <\/p>\n Analytical Techniques For Nanoparticle Drug Delivery 65 <\/p>\n Properties 65 <\/p>\n Production of Nanoparticles 65 <\/p>\n Measuring Dispersion of Nanoparticles 66 <\/p>\n Characterisation of Carrier Systems 67 <\/p>\n Nanocarriers 68 <\/p>\n Classification of Nanocarriers 68 <\/p>\n Multifunctional Nanocarriers - Drug Delivery And Medical \/ Biomedical Diagnostics 69 <\/p>\n Nanocarriers as Drug Carriers 69 <\/p>\n What Can Nanoparticles do in Drug Delivery? 69 <\/p>\n Polymer-Based Nanocarriers (Polymeric Nanoparticles) 73 <\/p>\n Lipid-Based Nanocarriers 75 <\/p>\n Organic Nanocarriers 78 <\/p>\n Inorganic Nanocarriers 78 <\/p>\n Disadvantages Associated With Nanocarriers 79 <\/p>\n The Most Relevant Technologies in The Key Area of Nanotechnology in Drug Delivery 80 <\/p>\n Stage of Development of Key Nanotechnologies Used in Drug Delivery 80 <\/p>\n Clinically Approved Nanocarrier-Based Drug Formulations With Presence on The Market <\/p>\n The First Nanoparticle Drug Delivery System Reaches The Market 81 <\/p>\n Present And Future Applications 84 <\/p>\n TECHNOLOGY ADOPTION ROADMAP 86 <\/p>\n Projected Product Pipeline For Nanocarrier-Based Drug Formulations In Drug Delivery <\/p>\n Market 86 <\/p>\n Available Applications Of Nanoparticles In Drug Delivery 87 <\/p>\n Semapimod\u00ae (cytokine, pharmasciences) 89 <\/p>\n Paxceed\u2122 89 <\/p>\n Theralux\u2122 90 <\/p>\n Nucryst\u00ae 90 <\/p>\n iSPERSE\u2122 91 <\/p>\n ANALYSIS OF TAM FOR NANOCARRIERS: 2000-2010 93 <\/p>\n TAM FORECAST FOR NANOCARRIERS: 2011-2021 99 <\/p>\n APPENDIX 108 <\/p>\n PUBLISHING ACTIVITY BY ORGANIZATION (2000-2010) 108 <\/p>\n To order this report:Drug Delivery Technology Industry: Nanotechnology for Drug Delivery : Global Market for Nanocarriers <\/p>\n More Market Research Report <\/p>\n Check our Industry Analysis and Insights <\/p>\n Nicolas Bombourg More: NEW YORK, Feb. 13, 2012 \/PRNewswire\/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Nanotechnology for Drug Delivery : Global Market for Nanocarriers http:\/\/www.reportlinker.com\/p0770731\/Nanotechnology-for-Drug-Delivery---Global-Market-for-Nanocarriers.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology<\/a> Nanocarriers will account for 40% of a $136 billion nanotechnology-enabled drug delivery market by 2021. Continue reading
Reportlinker
Email: nbo@reportlinker.com<\/a>
US: (805)652-2626
Intl: +1 805-652-2626 <\/p>\n<\/p>\n
\nNanotechnology for Drug Delivery : Global Market for Nanocarriers<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"